These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 26933402)

  • 1. Resveratrol inhibits proteinase-activated receptor-2-induced release of soluble vascular endothelial growth factor receptor-1 from human endothelial cells.
    Al-Ani B
    EXCLI J; 2013; 12():598-604. PubMed ID: 26933402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of proteinase-activated receptor 2 stimulates soluble vascular endothelial growth factor receptor 1 release via epidermal growth factor receptor transactivation in endothelial cells.
    Al-Ani B; Hewett PW; Cudmore MJ; Fujisawa T; Saifeddine M; Williams H; Ramma W; Sissaoui S; Jayaraman PS; Ohba M; Ahmad S; Hollenberg MD; Ahmed A
    Hypertension; 2010 Mar; 55(3):689-97. PubMed ID: 20124108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol inhibits the release of soluble fms-like tyrosine kinase (sFlt-1) from human placenta.
    Cudmore MJ; Ramma W; Cai M; Fujisawa T; Ahmad S; Al-Ani B; Ahmed A
    Am J Obstet Gynecol; 2012 Mar; 206(3):253.e10-5. PubMed ID: 22197494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting trophoblast PAR-1 overexpression suppresses sFlt-1-induced anti-angiogenesis and abnormal vascular remodeling: a possible therapeutic approach for preeclampsia.
    Zhao Y; Zheng Y; Liu X; Luo Q; Wu D; Liu X; Zou L
    Mol Hum Reprod; 2018 Mar; 24(3):158-169. PubMed ID: 29325127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia.
    Ahmad S; Ahmed A
    Circ Res; 2004 Oct; 95(9):884-91. PubMed ID: 15472115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and quantification of complexed and free soluble human vascular endothelial growth factor receptor-1 (sVEGFR-1) by ELISA.
    Hornig C; Behn T; Bartsch W; Yayon A; Weich HA
    J Immunol Methods; 1999 Jun; 226(1-2):169-77. PubMed ID: 10410982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic effect of soluble vascular endothelial growth factor receptor-1 in placental angiogenesis.
    Ahmad S; Ahmed A
    Endothelium; 2005; 12(1-2):89-95. PubMed ID: 16036320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The relativity of vascular endothelium growth factor receptor-1 and preeclampsia].
    Zou CL; Liu XH; Yue BM; Fu JH; He GL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Sep; 37(5):765-8. PubMed ID: 17037747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol inhibits release of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin and improves vascular dysfunction - implications as a preeclampsia treatment.
    Hannan NJ; Brownfoot FC; Cannon P; Deo M; Beard S; Nguyen TV; Palmer KR; Tong S; Kaitu'u-Lino TJ
    Sci Rep; 2017 May; 7(1):1819. PubMed ID: 28500309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble VEGFR-1 secreted by endothelial cells and monocytes is present in human serum and plasma from healthy donors.
    Barleon B; Reusch P; Totzke F; Herzog C; Keck C; Martiny-Baron G; Marmé D
    Angiogenesis; 2001; 4(2):143-54. PubMed ID: 11806246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.
    Chaiworapongsa T; Espinoza J; Gotsch F; Kim YM; Kim GJ; Goncalves LF; Edwin S; Kusanovic JP; Erez O; Than NG; Hassan SS; Romero R
    J Matern Fetal Neonatal Med; 2008 Jan; 21(1):25-40. PubMed ID: 18175242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids.
    Hornig C; Barleon B; Ahmad S; Vuorela P; Ahmed A; Weich HA
    Lab Invest; 2000 Apr; 80(4):443-54. PubMed ID: 10780661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia is responsible for soluble vascular endothelial growth factor receptor-1 (VEGFR-1) but not for soluble endoglin induction in villous trophoblast.
    Munaut C; Lorquet S; Pequeux C; Blacher S; Berndt S; Frankenne F; Foidart JM
    Hum Reprod; 2008 Jun; 23(6):1407-15. PubMed ID: 18413304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.
    Kaza E; Ablasser K; Poutias D; Griffiths ER; Saad FA; Hofstaetter JG; del Nido PJ; Friehs I
    Cardiovasc Res; 2011 Feb; 89(2):410-8. PubMed ID: 20935166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma.
    Ebos JM; Bocci G; Man S; Thorpe PE; Hicklin DJ; Zhou D; Jia X; Kerbel RS
    Mol Cancer Res; 2004 Jun; 2(6):315-26. PubMed ID: 15235107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1.
    Cudmore M; Ahmad S; Al-Ani B; Fujisawa T; Coxall H; Chudasama K; Devey LR; Wigmore SJ; Abbas A; Hewett PW; Ahmed A
    Circulation; 2007 Apr; 115(13):1789-97. PubMed ID: 17389265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-metastatic effect of vascular endothelial growth factor receptor 2 extracellular domain gene-modified dendritic cell vaccination in murine model with experimental pulmonary metastasis].
    Pan JP; Weng YS; Wu QQ
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):646-9. PubMed ID: 17274366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor-mediated decrease in plasma soluble vascular endothelial growth factor receptor-2 levels as a surrogate biomarker for tumor growth.
    Ebos JM; Lee CR; Bogdanovic E; Alami J; Van Slyke P; Francia G; Xu P; Mutsaers AJ; Dumont DJ; Kerbel RS
    Cancer Res; 2008 Jan; 68(2):521-9. PubMed ID: 18199548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of Vegfr-2 and its soluble form in preeclampsia.
    Munaut C; Lorquet S; Pequeux C; Coulon C; Le Goarant J; Chantraine F; Noël A; Goffin F; Tsatsaris V; Subtil D; Foidart JM
    PLoS One; 2012; 7(3):e33475. PubMed ID: 22428059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.